The Virginia Catalyst will host a free webinar in conjunction with Virginia Bio:
“Funding for Virginia Public-Private Biotech Partnerships…Come Learn How to Score and Win!”
Wednesday, April 22 Noon – 1:00 pm
Join us on Zoom at: https://zoom.us/j/644376195
Panel members include:
Mike Grisham, President and CEO of Virginia Catalyst
Mickey Kim, former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute, Inova Health System
James Powers, Chairman and CEO, HemoShear Theapeutics, LLC
Thomas D. Roberts III, General Partner, Harbert Growth Partners, Harbert Management Corporation
Timeline and how to apply for Virginia Catalyst Grant Round 11
How to score highly, get funding and position your company and research university for significant follow-on funding from large corporations, venture capitalists, DARPA, NIH and philanthropic foundations
Read the full press release here
Emphasis will be placed on Innovative Projects Focused on Solutions for COVID-19 and other Infectious Disease
RICHMOND, VA – April 1, 2020 – The Virginia Catalyst, formerly known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 11 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advancing Virginia’s economy.
While all life science projects will be accepted for Grant Round 11, given the impact of COVID-19, emphasis will be placed on projects within the areas of infectious disease, immunology, vaccine and drug discovery, and innovative service delivery models including telehealth and telemedicine.
Read the full article here